当前位置: X-MOL 学术J. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Why Does MRI-Targeted Biopsy Miss Clinically Significant Cancer?
The Journal of Urology ( IF 6.6 ) Pub Date : 2021-08-26 , DOI: 10.1097/ju.0000000000002182
Cheyenne Williams 1 , Michael Ahdoot 1 , Michael A Daneshvar 1 , Christian Hague 1 , Andrew R Wilbur 1 , Patrick T Gomella 1 , Joanna Shih 2 , Nabila Khondakar 1 , Nitin Yerram 1 , Sherif Mehralivand 3 , Sandeep Gurram 1 , Minhaj Siddiqui 4 , Paul Pinsky 5 , Howard Parnes 5 , Maria Merino 6 , Bradford Wood 7 , Baris Turkbey 3 , Peter A Pinto 1
Affiliation  

Multiple studies demonstrate MRI-targeted biopsy detects more clinically significant cancer than systematic biopsy, however some clinically significant cancers are detected by systematic biopsy only. While these events are rare, we sought to perform a retrospective analysis of these cases to ascertain the reasons that MRI-targeted biopsy missed clinically significant cancer, which was subsequently detected on systematic prostate biopsy.

中文翻译:

为什么 MRI 靶向活检会遗漏具有临床意义的癌症?

多项研究表明,与系统活检相比,MRI 靶向活检可检测到更多具有临床意义的癌症,但仅通过系统活检可检测到一些具有临床意义的癌症。虽然这些事件很少见,但我们试图对这些病例进行回顾性分析,以确定 MRI 靶向活检错过具有临床意义的癌症的原因,这些癌症随后在系统性前列腺活检中被发现。
更新日期:2021-08-26
down
wechat
bug